Introduction
Derivatives of 1,3,4-thiadiazoles and 1,2,4-triazole are known to exhibit anti-inflammatory, antiviral, analgesic, antimicrobial, anticonvulsant and antidepressant activity, the latter being usually explored by the forced swim test [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Among the pharmacological profiles of 1,3,4-thiadiazoles and 1,2,4-triazoles, their antimicrobial, anticonvulsant and antidepressant properties seem to be the best documented. Triazoles, in particular, substituted-1,2,4-triazoles and the open-chain thiosemicarbazide OPEN ACCESS counterparts of 1,2,4-triazole, are among the various heterocycles that have received the most attention during the last two decades as potential antimicrobial agents [11] . Substitutions including thio-, alkylthioand alkenylthio-derivatives have been carried out primarily at the 3-position of the 1,2,4-triazole ring, to afford potential antimicrobial agents that will overcome the abovementioned resistance problems.
Heterocycles containing a 1,2,4-triazole or 1,3,4-thiadiazole moiety, and the compounds consisting of 1,2,4-triazole and 1,3,4-thiadiazole condensed nucleus systems constitute a class of compounds possessing a wide spectrum of biological activities such as anti-inflammatory, antiviral and antimicrobial and antitumoral properties [12] [13] [14] [15] [16] [17] [18] . It was reported that more efficacious antibacterial compounds can be designed by joining two or more biologically active heterocyclic systems together in a single molecular framework. Keeping this observation in mind, this paper has presented the synthesis of new triazole thiadiazole derivatives incorporating different pharmacophores as hybrid molecules possessing antioxidant and antimicrobial activities [19] .
Results and Discussion
The synthesis of the intermediate and target compounds was performed according to the reactions outlined in Scheme 1. The starting compounds 1a,b were prepared following a previously reported literature procedure [20] . The reaction of compounds 1a,b with ethyl bromoacetate in the presence of sodium ethoxide produced diethyl 2,2'-(4,4'(butane-1,4-diyl/hexane-1,6-diyl)bis(3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4,1-diyl))diacetates 2a,b. The ethoxy group on compounds 2a,b is an good leaving group for further nucleophilic substitution, thus reactions of 2a,b with hydrazine hydrate converted these esters into the corresponding 2,2'-(4,4'(butane-1,4-diyl/hexane-1,6-diyl)bis(3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4,1diyl))diacetohydrazides derivatives 3a,b which were employed as key intermediates for synthesis of the target compounds.
Analytical and spectroscopic data of compounds 2a,b confirmed this reaction by the additional signals derived from the -CH 2 CO 2 Et group at the expected chemical shift values. Moreover, compounds 2a,b gave a stable M+1 ion peak. The 1 H-NMR spectra of compounds 3a,b displayed no signals belonging to the -OCH 2 CH 3 group; instead, new signals derived from the hydrazide structure appeared at 3.38-3.57 ppm (-NHNH 2 ) and 9.16-9.17 ppm (-NHNH 2 ) integrating for two protons and one proton, respectively (D 2 O exchange). Furthermore, compounds 3a,b gave relatively stable M+1 ion peaks.
were obtained by the reaction of compounds 3a,b with 4-fluorophenylisothiocyanate (4), 4-bromophenylisothiocyanate (5), or p-tolylisothiocyanate (6) . The reaction was carried out at reflux temperature in ethanol and afforded the desired thiosemicarbazide derivatives, which were the starting materials for further cyclizations. The IR spectrum of compounds 4a,b-6a,b displayed a broad signal at 3245 cm Br 8a, 11a 8b, 11b
The treatment of compounds 4a,b-6a,b with cold concentrated sulfuric acid caused the conversion of the thiosemicarbazide structures into 1,3,4-thiadiazole rings; thus, 4,4'-( butane-1,4-diyl/hexane-1,6-diyl)bis 
5a 5b H 2 SO 4 NaOH The newly synthesized compounds were screened for antioxidant properties by radical scavenging methods such as the 1,1-diphenyl-2-picryl hydrazyl (DPPH) assay. Compounds 4a,b-6a,b possessing triazole-thiosemicarbazides have better antioxidant activity than 5a,b. While compounds 4a,b and 6a,b have fluorine and methyl group substituents on the phenyl rings, compounds 5a,b have bromine substituents. Thiosemicarbazide derivatives 4a,b-6a,b also showed antibacterial activity against microorganisms. The 1,2,4-triazole nucleus is one of the active components present in many standard drugs and it is known to increase the pharmacological activity of the corresponding molecules. As an biological group, thiosemicarbazide groups in the triazole compounds should be considered for the synthesis of lead compounds in search of antioxidant and antimicrobial activity. All of the synthesized compounds were tested for antimicrobial activity. The antimicrobial screening suggests that among the newly synthesized compounds, 2a, 3a, 4a,b-11a,b exhibited moderate activity against some of the tested microorganisms.
Experimental

General Information
Melting points were measured on an electrothermal apparatus and are uncorrected. 
General Method for the Synthesis of Compounds 2
The corresponding compound 1 (0.01 mol) was refluxed with an equivalent amount of sodium in absolute ethanol for 2 h. Then, ethyl bromoacetate (0.01 mol) was added and the mixture was refluxed for an additional 5 h. After evaporation of the solvent under reduced pressure at 35-40 °C, a solid appeared. This was recrystallized from 1:1 ethanol/water to afford the desired product. 
Diethyl 2,2'-(4,4'(butane-1,4-diyl)bis(3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4,1-diyl))diacetate (2a
Diethyl 2,2'-(4,4'(hexane-1,6-diyl)bis(3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4,1-diyl))diacetate (2b
General Method for the Synthesis of Compounds 3
A solution of the corresponding compound 2 (10 mmol) in n-butanol was refluxed with hydrazine hydrate (25 mmol) for 4 h. After cooling it to room temperature, a white solid appeared. This was recrystallized from 1:2 ethanol-water to obtain the desired compound. 
2,2'-(4,4'(Butane-1,4-diyl)bis(3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4,1-diyl)) diacetohydrazide (3a
).
2,2'-(4,4'(Hexane-1,6-diyl)bis(3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4,1-diyl)) diacetohydrazide (3b
General Method for the Synthesis of Compounds 4-6
A mixture of corresponding compound 3 (10 mmol) and 4-fluorophenylisothiocyanate (for compounds 4), 4-bromophenylisothiocyanate (for compounds 5) or p-tolylisothiocyanate (for compounds 6) (15 mmol) was refluxed in ethanol for 4 h. The solution was cooled and a white solid appeared. This was filtered and recrystallized from ethanol to afford the desired product. 6-(1-(2-(2-(4-fluorophenylcarbonothioyl) 
N-(4-Fluorophenyl)-2-(2-(4-(4-(1-(2-(2-(4-fluorophenylcarbamothioyl)hydrazinyl)-2-oxoethyl)-3-methyl-5-oxo-1H-1,2,4-triazole-4(5H)-yl)butyl)-3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-1-yl)acetyl)hydrazinecarbothioamide (4a
N-(4-Fluorophenyl)-2-(2-(4-(
hydrazinyl)-2-oxoethyl)-3- methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4(5H)-yl)hexyl)-3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-1- yl)acetyl)hydrazinecarbothioamide (4b
N-(4-Bromophenyl)-2-(2-(4-(4-(1-(2-(2-(4-bromophenylcarbamothioyl)hydrazinyl)-2-oxoethyl)-3-methyl-5-oxo-1H-1,2,4-triazole-4(5H)-yl)butyl)-3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-1-yl)-acetyl)hydrazinecarbothioamide (5a
. 
N-(4-Bromophenyl)-2-(2-(4-(6-(1-(2-(2-(4-bromophenylcarbonothioyl)hydrazinyl)-2-oxoethyl)-3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-4(5H)-yl)hexyl)-3-methyl-5-oxo-4,5-dihydro-1,2,4-triazole-1-yl)acetyl)hydrazinecarbothioamide (5b
N-(p-Tolyl))-2-(2-(3-methyl-4-(4-(3-methyl-5-oxo-1-(2-oxo-2-(2-(p-tolylcarbamothioyl)hydrazinyl)-ethyl)-1H-1,2,4-triazole-4(5H)-yl)butyl)-5-oxo-4,5-dihydro-1,2,4-triazole-1-yl)acetyl)hydrazinecarbothioamide (6a
N-(p-Tolyl))-2-(2-(3-methyl-4-(4-(3-methyl-5-oxo-1-(2-oxo-2-(2-(p-tolylcarbamothioyl)hydrazinyl)-ethyl)-1H-1,2,4-triazole-4(5H)-yl)hexyl)-5-oxo-4,5-dihydro-1,2,4-triazole-1-yl)acetyl)hydrazinecarbothioamide (6b
General Method for the Synthesis of Compounds 7-9
A mixture of corresponding thiosemicarbazides 4-6 (10 mmol) in cold concentrated sulfuric acid (30 mL) was stirred for 10 min then, the mixture was allowed to reach room temperature. After stirring for an additional 30 min, the resulting solution was poured into ice cold water and made alkaline to pH 8 with ammonia. The precipitated product was filtered, washed with water and recrystallized from ethanol to afford the pure compounds. -1,4-diyl)bis(2-((5-(4-bromophenylamino)1,3,4-thiadiazole-2-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) 
4,4'-(Butane-1,4-diyl)bis(2-((5-(4-fluorophenylamino)1,3,4-thiadiazole-2-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (7a
4,4'-(Hexane-1,6-diyl)bis(2-((5-(4-fluorophenylamino)1,3,4-thiadiazole-2-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (7b
4,4'-(Butane
4,4'-(Hexane-1,6-diyl)bis(2-((5-(4-bromophenylamino)1,3,4-thiadiazole-2-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (8b
4,4'-(Butane-1,4-diyl)bis(2-((5-(p-toluidino)1,3,4-thiadiazole-2-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (9a
4,4'-(Hexane-1,6-diyl)bis(2-((5-(p-toluidino)1,3,4-thiadiazole-2-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (9b
General Method for the Synthesis of Compounds 10 and 11
A solution of corresponding carbothioamide (4-6) (10 mmol) inequivalent amount of 2 N NaOH solution was refluxed for 3 h. The resulting solution was cooled to room temperature and acidified topH 3-4 with 37% HCl. The precipitate formed was filtered, washedwith water and recrystallized from dimethyl sulfoxide/water (1:1) to afford the desired compound. 
4,4'-(Butane-1,4-diyl)bis(2-((4-(4-fluorophenyl)-5-mercapto-4H-1,2,4-triazole-3-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (10a
4,4'-(Hexane-1,6-diyl)bis(2-((4-(4-fluorophenyl)-5-mercapto-4H-1,2,4-triazole-3-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (10b
4,4'-(Butane-1,4-diyl)bis(2-((4-(4-bromophenyl)-5-mercapto-4H-1,2,4-triazole-3-yl)methyl)-5-methyl-2H-1,2,4-triazole-3(4H)-one) (11a
Antioxidant Activity
DPPH assay: The hydrogen atoms or electrons donation ability of the samples was measured from the bleaching of purple coloured methanol solution of DPPH. This spectrophotometric assay uses stable radical 2,2'-diphenylpicrylhydrazyl (DPPH) as a reagent [21, 22] . Fifty microliters of various concentrations of the samples in methanol was added to a 0.004% methanol solution of DPPH (5 mL). After a 30 min incubation period at room temperature the absorbance was read against a blank at 517 nm. Inhibition free radical DPPH in percent (I %) was calculated in following way: I %: (A blank − A sample /A blank ) × 100 where A blank is the absorbance of the control reaction (containing all reagents except the test sample), and A sample is the absorbance of the test compound. Sample concentration providing 50% inhibition (IC 50 ) was calculated form the graph plotted inhibition percentage against extract concentration. Tests were carried out in triplicate. Butylated hydroxytoluene (BHT) was used as positive control. The results are shown in the Table 1 and Figure 1 . 
Conclusions
In this study, a series of new triazole derivatives having carbohydrazide, thiosemicarbazide, thiadiazole and triazole-thiol moieties, respectively, at the 1-position was synthesized, and their antioxidant and antimicrobial activities were evaluated. It was observed that in vitro the newly synthesized triazole-thiosemicarbazides 4a,b-6a,b possess highly potent antioxidant properties and triazole/triazole-thiol derivatives 10a,b-11a,b possess moderate potent antioxidant properties .  Compounds 7a,b, 8a,b and 9a,b , containing triazole-thiadiazole and triazole/triazole-thiol moieties didn't show antioxidant properties. All newly synthesized compounds were screened for their antibacterial and antifungal activities by the inhibition zones (mm) method. Almost all the synthesized compounds showed significant activity against bacteria, while no compounds showed activity against fungi (Aspergillus, Fusarium, Rhizopus). In particular the 1,2,4-triazole-possessing thiosemicarbazides 4a,b-6a,b show both antibacterial and antifungal activities.
